Index of artpub/2024/313088/

Querol, Luis
Efficacy, safety and tolerability of rozanolixizumab in patients with chronic inflammatory demyelinating polyradiculoneuropathy : A randomised, subject-blind, investigator-blind, placebo-controlled, phase 2a trial and open-label extension study
2024
https://ddd.uab.cat/record/313088